Cao, Liang
National Institutes of Health · National Cancer Institute
3 papers on CoChatORCID 0000-0001-7293-8338
Most cited papers
- Verified
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Strauss, J., Heery, C. R., Schlom, J., Madan, R. A., Cao, L., Kang, Z., Lamping, E., Marté, J. L., Donahue, R. N., Grenga, I., et al. (2018) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 406
- Verified
Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion
Terzuoli, E., Puppo, M., Rapisarda, A., Uranchimeg, B., Cao, L., Burger, A. M., Ziche, M., & Melillo, G. (2010) · Cancer Research
Cancer, Hypoxia, and MetabolismFlavonoids in Medical Research
Cited by 111
- Verified
LMP1 of Epstein–Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression
Yang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene
Telomeres, Telomerase, and SenescenceViral-associated cancers and disorders
Cited by 71
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free